Drug firm ZS Pharma has appointed Genomic Health CEO Kimberly Popovits to its board of directors. Popovits, who is also president of Genomic Health and heads the company's board of directors, brings more than 30 years of life sciences industry experience. Before becoming CEO of Genomic Health in 2002, Popovits was senior VP of marketing and sales at Genentech, where she worked for 15 years, spearheading commercialization efforts.
Popovits serves on the boards of several other entities, including Northern California's life science association CLSA and the American Clinical Laboratory Association. She is also president of The Coalition for 21st Century Medicine and the Women Health Care Executives named her Woman of the Year in 2008.